Form 10-KT/A - Transition reports [Rule 13a-10 or 15d-10]: [Amend]
SEC Accession No. 0001165527-10-000897
Filing Date
2010-11-26
Accepted
2010-11-26 08:52:17
Documents
5
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K g4557.txt 10-KT/A 209836
2 CEO SECTION 302 CERTIFICATION ex31-1.txt EX-31.1 3756
3 CFO SECTION 302 CERTIFICATION ex31-2.txt EX-31.2 3759
4 CEO SECTION 906 CERTIFICATION ex32-1.txt EX-32.1 1467
5 CFO SECTION 906 CERTIFICATION ex32-2.txt EX-32.2 1472
  Complete submission text file 0001165527-10-000897.txt   222025
Mailing Address 71130, 198-8060 SILVER SPRING BLVD. CALGARY A0 T3B 5K2
Business Address 71130, 198-8060 SILVER SPRING BLVD. CALGARY A0 T3B 5K2 403-537-2516
UPSTREAM BIOSCIENCES INC. (Filer) CIK: 0001174891 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: 10-KT/A | Act: 34 | File No.: 000-50331 | Film No.: 101216285
SIC: 2835 In Vitro & In Vivo Diagnostic Substances